⌘+K

Company description

Vivesto has streamlined its business to strengthen financial resilience and enhance its ability to create shareholder value using existing resources. The company is primarily focused on Paccal Vet, which is being developed for veterinary oncology, and Cantrixil, which is being evaluated across both veterinary and human oncology indications.

Key industry drivers

  • The global incidence of cancer is projected to increase, both in humans and pets, driving demand for treatments.

  • Demand for more effective targeted therapies to improve overall survival and quality of life.

Industry outlook

  • Sales of veterinary oncology drugs are growing annually by some 10–12%, according to Global Markets Insights.

  • Iqvia projects the overall oncology pharmaceutical market to grow by 12–13% per year up to 2028.

  • Key peers

    We view Active Biotech, Cantargia, Intervacc, and Spago Nanomedical as the closest peers to Vivesto.

    Shareholders

    Name

    Capital

    Votes

    Per Arwidsson

    40.0 %

    40.0 %

    Avanza Pension

    4.8 %

    4.8 %

    Christer Hasslebäck

    4.3 %

    4.3 %

    Nordnet Pensionsförsäkring

    2.1 %

    2.1 %

    Swedbank Försäkring

    1.4 %

    1.4 %

    Johan Zetterstedt

    1.3 %

    1.3 %

    About DNB Carnegie Access

    DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

    Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

    Private Banking

    Tailored wealth management. Your financial future, personalized.

    Montrose

    A digital investment platform designed for passionate investors.

    DNB Carnegie

    Leading Nordic investment bank and wealth management.

    © Copyright DNB Carnegie Investment Bank AB